Stockreport

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise [Yahoo! Finance]

Coherus BioSciences, Inc.  (CHRS) 
Last coherus biosciences, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.coherus.com
PDF – Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI ® , a revenue-generating and differentiated PD-1 inhibitor; – Casdozokitu [Read more]